Lopid, Gemfibrozil

Lopid, Gemfibrozil Newswire

Comprehensive Real-Time News Feed for Lopid, Gemfibrozil (generic).

Results 1 - 9 of 9 in Lopid, Gemfibrozil (generic)

  1. Physicians should not be expected to blindly follow guidelinesRead the original story

    Tuesday | Kevin, M.D.

    Barron Lerner thinks he understands doctor's motives. In his recent article in the Atlantic he laments that physicians act on tradition and emotion over adopting new science.

    Comment?

  2. Tribute Pharmaceuticals Appoints JSB-Partners to Lead Partnership...Read the original story

    Mar 12, 2014 | Hispanic Business

    The Investigational New Drug Application for Bezalip SR was cleared by the . "We are delighted to have the support of JSB as we continue to work towards the partnering and ultimately the regulatory approval of Bezalip SR in the U.S.," said , President and CEO of Tribute.

    Comment?

  3. Liver Drug Race: Intercept Pharma Vs. RivalsRead the original story

    Jan 26, 2014 | Seeking Alpha

    In mid-January a little-known biotech Intercept Pharmaceuticals' market capitalization leaped from $1.4 billion to $8.6 billion in a matter of days and the stock price touched briefly a high of $497.00.

    Comment?

  4. Mylan Inc. Launches Generic Prandin TabletsRead the original story

    Jan 24, 2014 | BioSpace

    This product is the generic version of Novo Nordisk's PrandinA , which is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

    Comment?

  5. Mylan Launches Generic Prandin TabletsRead the original story

    Jan 23, 2014 | Freshnews

    Mylan Inc. today announced that its U.S.-based subsidiary Mylan Pharmaceuticals Inc. has launched Repaglinide Tablets, 0.5 mg, 1 mg and 2 mg.

    Comment?

  6. FDA Approves Orenitram (treprostinil) Extended-Release Tablets for...Read the original story

    Dec 30, 2013 | Drugs.com

    United Therapeutics Corporation announced today that the United States Food and Drug Administration has approved Orenitram Extended-Release Tablets for the treatment of pulmonary arterial hypertension in WHO Group I patients to improve exercise capacity.

    Comment?

  7. United Therapeutics Corporation Hits All-Time High As FDA OKs Lung...Read the original story

    Dec 23, 2013 | BioSpace

    United Therapeutics Corporation Hits All-Time High As FDA OKs Lung Disease Drug; Stock Up 19.25% At 9:56AM ET /PRNewswire/ -- United Therapeutics Corporation announced today that the United States Food and Drug Administration has approved Orenitram Extended-Release Tablets for the treatment of pulmonary arterial hypertension in WHO Group I patients ... (more)

    Comment?

  8. FDA Approves Orenitrama (treprostinil) Extended-Release Tablets for ...Read the original story

    Dec 20, 2013 | Sys-Con Media

    "This approval marks the first time that the FDA has approved an orally administered prostacyclin analogue for any disease - and our fifth approval from the FDA for treatment of PAH - supporting our mission of providing a wider choice of PAH therapies for physicians and patients," said , Ph.D., United Therapeutics' President and Chief Operating ... (more)

    Comment?

  9. Possible modulation of 0046AS and PTP-1B signaling in ameliorative...Read the original story

    Oct 25, 2013 | BioMed Central

    Bombax ceiba Linn., commonly called as Semal, is used in various gastro-intestinal disturbances.

    Comment?